miR-139 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNA-139 (miR-139) is recognized for its tumor suppressor functions across various cancers.
• Osteosarcoma (OS) is a prevalent and aggressive bone malignancy primarily affecting pediatric and adolescent populations.

Purpose of the Study:

• To investigate the inhibitory role of miR-139 and its target, ROCK1, in osteosarcoma progression.
• To elucidate the molecular mechanisms underlying miR-139's tumor-suppressive activity in OS cells.

Main Methods:

• Quantitative real-time PCR to assess miR-139 expression levels in OS.
• Cell proliferation, migration, and invasion assays following miR-139 overexpression or ROCK1 knockdown.
• Western blotting to analyze protein expression changes (β-CATENIN, p-AKT, E-CADHERIN, p53).
• Luciferase reporter assays to confirm direct binding of miR-139 to the ROCK1 3'UTR.

Main Results:

• miR-139 expression was significantly downregulated in osteosarcoma tissues.
• Overexpression of miR-139 suppressed OS cell proliferation, migration, and invasion.
• miR-139 directly targeted ROCK1 by binding to its 3' untranslated region (3'UTR).
• Silencing ROCK1 mimicked the inhibitory effects of miR-139 on OS cell behaviors.
• ROCK1 re-expression reversed the suppressive effects of miR-139.
• Both miR-139 and ROCK1 knockdown modulated key signaling pathways, including β-CATENIN, p-AKT, E-CADHERIN, and p53.

Conclusions:

• miR-139 functions as a tumor suppressor in osteosarcoma by targeting ROCK1.
• The miR-139/ROCK1 axis influences critical cellular processes like proliferation and invasion in OS.
• Modulation of the miR-139/ROCK1 pathway impacts downstream signaling molecules involved in cancer progression.